We are live on ! Find out more
BBLGW

Bone Biologics Corp Warrants
BBLGW

1 hedge funds and large institutions have $44.9K invested in Bone Biologics Corp Warrants in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.41% less ownership

Funds ownership: 0.78% → 0.37% (-0.41%)

50% less funds holding

Funds holding: 2 → 1 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

86% less capital invested

Capital invested by funds: $324K → $44.9K (-$280K)

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MG
Marex Group
+$37.8K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$324K
2
UBS Group
UBS Group
Switzerland
-$846
Name Holding Trade Value Shares
Change 		Change in
Stake
MG
1
Marex Group
$44.9K +$37.8K +11,460 New
Citadel Advisors
2
Citadel Advisors
Florida
– -$324K -24,329 Closed
UBS Group
3
UBS Group
Switzerland
– -$846 -61 Closed

BBLGW Hedge Fund Activity: Q4 2023 in Review

1 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics Corp Warrants (BBLGW) for Q4 2023, worth a combined $44.9K — down 86% from $324K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BBLGW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Marex Group, opening a new position worth an estimated $37.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $324K sold.

  • 1 institutional investor held Bone Biologics Corp Warrants (BBLGW) as of Q4 2023, down from 2 in Q3 2023.
  • Funds reported $44.9K of Bone Biologics Corp Warrants stock for Q4 2023, down 86% quarter-over-quarter.
  • 1 fund opened new Bone Biologics Corp Warrants positions in Q4 2023 and 2 closed out, a net change of -1 holder.
  • The largest Bone Biologics Corp Warrants buyer in Q4 2023 was Marex Group, an estimated $37.8K added.
  • The largest Bone Biologics Corp Warrants seller in Q4 2023 was Citadel Advisors, an estimated $324K sold.

Based on aggregated 13F filings for Q4 2023.